CRSP
Crispr Therapeutics AG
57.30$
+3.4%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.50 | -1.18 | 1.34 | -1.13 | -1.25 | -0.59 | -0.63 | -1.31 | -0.93 | -1.03 | -1.13 | -1.99 | -4.96 | |
| 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.05 | 0.05 | 0.06 | 0.04 | 0.09 | 0.24 | |
| 0.25 | 0.23 | 0.24 | 0.28 | 0.25 | 0.26 | 0.24 | 0.20 | 0.18 | 0.20 | 0.17 | 0.35 | 0.88 | |
| 0.66 | -2.51 | 2.57 | 0.12 | -0.47 | -0.28 | 0.64 | -0.19 | 0.12 | 0.25 | -0.16 | -0.20 | -0.01 | |
| 0.03 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.02 | |
| 1.53 | -1.00 | -1.20 | -1.49 | -1.90 | 1.24 | -0.23 | 0.80 | -1.31 | 0.41 | -4.28 | -4.83 | -9.94 | |
| – | – | – | -0.01 | 0.01 | – | – | 0.82 | 0.78 | – | – | -0.01 | – | |
| 0.02 | 0.48 | 3.74 | -0.01 | 0.11 | 0.20 | 0.12 | 0.03 | 3.25 | 1.29 | 6.16 | 6.21 | 16.62 | |
| 1.04 | -1.70 | 3.89 | -2.63 | -3.04 | 0.85 | -0.73 | -0.48 | 1.02 | 0.68 | 0.71 | -0.62 | 1.69 | |
| -0.53 | -1.19 | 1.33 | -1.13 | -1.26 | -0.59 | -0.63 | -1.31 | -0.93 | -1.03 | -1.14 | -2.01 | -4.98 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.